文献速递生殖医学

男性年龄对父源性非整倍体的影响:囊胚活检后单核苷酸多态性微阵列结果

Impact of male age on paternal aneuploidy: single-nucleotide polymorphism microarray outcomes following blastocyst biopsy.
PubMed 文献 · Reprod Biomed Online · 2023-06-10

这项多中心回顾性研究分析了2012至2021年间681个辅助生殖技术周期中2409枚囊胚的单核苷酸多态性微阵列植入前遗传学检测结果,按男方取精年龄分为<35岁、35-39岁和≥40岁三组。结果显示父源性整条染色体非整倍体率在各组间无显著差异(P=0.7561),父源性缺失亦无显著差异(4.8% vs 2.5%和2.8%,P=0.5292)。结论认为高龄父亲(≥40岁)与父源性非整倍体发生率无显著关联,高龄父亲可能不是植入前遗传学检测的指征。

要点

  • 父源性整条染色体非整倍体率在<35岁、35-39岁和≥40岁组间无显著差异(P=0.7561)。
  • 父源性缺失在高龄父亲(≥40岁)组为4.8%,与较年轻组的2.5%和2.8%相比无显著差异(P=0.5292)。
  • 父源性缺失是母源性缺失的2.9倍(P=0.0084),且不依赖于年龄分层。

核心结论

  • 高龄父亲(≥40岁)与植入前胚胎父源性非整倍体发生率无显著关联,无论非整倍体类型或复杂程度如何。
  • 因此,高龄父亲可能不是植入前遗传学检测的指征。

研究设计与样本

  • 多中心回顾性研究,分析2012至2021年间681个辅助生殖技术周期中389名男性患者的2409枚囊胚的SNP微阵列植入前遗传学检测结果,用于整条染色体非整倍体分析。
  • 节段性非整倍体分析纳入2016至2021年间242个辅助生殖技术周期中140名男性的867枚胚胎。
  • 按男方取精时年龄分为<35岁、35-39岁和≥40岁三组,采用卡方检验和/或Fisher精确检验比较父源性和母源性非整倍体率。

主要发现

  • 父源性整条染色体非整倍体率总体在组间无显著差异(P=0.7561);按类型(三体和单体:P=0.2235和0.8156)或复杂程度(单个 vs 2、3或≥4个非整倍体:P=0.9733、0.7517、0.669和0.1481)分层亦无显著差异。
  • 母源性整条染色体非整倍体率在组间有差异(P<0.0001),与平均母亲年龄的差异一致(P<0.001)。
  • 父源性缺失是母源性缺失的2.9倍(P=0.0084),且不依赖于年龄分层。
  • 高龄父亲(≥40岁)组父源性缺失为4.8%,与较年轻组的2.5%和2.8%相比无显著差异(P=0.5292)。
  • 单个染色体非整倍体率过低,无法进行统计学比较。

临床怎么用

  • 作者认为高龄父亲可能不是植入前遗传学检测的指征。

局限性

  • 单个染色体非整倍体率过低,无法进行统计学比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does advanced paternal age (APA; ≥40 years) contribute to a higher incidence of paternal origin aneuploidy in preimplantation embryos? DESIGN: This was a multicentre retrospective study of single-nucleotide polymorphism (SNP) microarray (Natera and Karyomapping) preimplantation genetic testing (PGT) outcomes of blastocyst-stage embryos. Whole-chromosome aneuploidy analysis was performed on 2409 embryos from 389 male patients undertaking 681 assisted reproductive technology (ART) cycles between 2012-2021. Segmental aneuploidy analysis was performed on 867 embryos from 140 men undertaking 242 ART cycles between 2016-2021. Embryos were grouped based on paternal age at sperm collection: <35, 35-39 and ≥40 years. Paternal and maternal origin aneuploidy rates were compared between groups using chi-squared and/or Fisher's exact tests. RESULTS: There was no significant difference across groups in paternal origin whole-chromosome aneuploidy rate, overall (P=0.7561) or when segregated by type (trisomy and monosomy: P=0.2235 and 0.8156) or complexity (single versus 2, 3 or ≥4 aneuploidies: P=0.9733, 0.7517, 0.669 and 0.1481). Conversely, maternal origin whole-chromosome aneuploidy rate differed across groups (P<0.0001) in alignment with differing mean maternal age (P<0.001). Paternal origin deletions were 2.9-fold higher than maternal origin deletions (P=0.0084), independent of age stratification. No significant difference in paternal origin deletions was observed with APA ≥40 compared with the younger age groups (4.8% versus 2.5% and 2.8%, P=0.5292). Individual chromosome aneuploidy rates were too low to perform statistical comparisons. CONCLUSIONS: No significant association was found between APA and the incidence of paternal origin aneuploidy in preimplantation embryos, irrespective of type or complexity. Thus, APA may not be an indication for PGT.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Samarasekera T, Willats E, Green MP, et al. Impact of male age on paternal aneuploidy: single-nucleotide polymorphism microarray outcomes following blastocyst biopsy. Reprod Biomed Online. 2023. PMID: 37619516. doi:10.1016/j.rbmo.2023.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。